Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility

National Medical Journal of China

Volumn 87, Issue 43, 2007, Pages 3064-3068

  Gu, Yan Fei ^a   Zhang, Zong De ^a   Zhang, Shu Cai ^a   Zheng, Su Hua ^a   Jia, Hong Yan ^a   Gu, Shu Xiang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytochrome P 450; Lung neoplasms; Polymorphism, restriction fragment length

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1;

ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; NULL ALLELE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SMOKING;

EID: 38849098393     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Singhal SS, Saxena M, Ahmad H, et al. Glutathione S-transferase of mouse-liver:sex-related differences in the expression of various isozymes. Biochim Biophys Acta, 1992, 1116:137-146.
2. Le Marchand L, Sivaraman L, Pierce L, et al. Associations of CYP1A, GSTM1 and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tabacco carcinogens. Cancer Res, 1998, 58:4858-4863.
3. Song N, Tan W, Xing DY, et al. CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis, 2001, 22:11-16.
4. Oyama T, Sugio K, Uramoto H, et al. Icreased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis. Front Biosci, 2007, 12:4497-4503.
5. Yang M, Choi Y, Hwangbo B, et al. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer, 2007, 57:135-142.
6. Oyama T, Kagawa N, Kunugita N, et al. Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci, 2004, 9:1967-1976.
7. Oyama T, Sugio K, Uramoto H, et al. Cytochrome P450 expression(CYP) in non-small cell lung cancer. Front Biosci, 2007, 12:2299-2308.
8. Chinese source.
9. Yokoi T, Kamataki T. Genetic polymorphism of drug metaboliziing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm Res, 1998, 15:517-524.
10. Chinese source.
11. Marchard LL, Wilkinson GR, Wilkens LR. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Janpanese using chlorzoxazone. Cancer Epidemiol Biomarkers Pree, 1999, 8:495-500.
12. Chinese source.
13. Chinese source.
14. Benhamous S, Lee WJ, Alexandrie AK, et al. Meta-and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 2002,23:1343-1350.